Skip to content

Important safety information

Prescribing information

This site is intended for US
patients only.

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

Important safety information

Prescribing information

This site is intended for US
healthcare professionals.

Author: increlex_admin

INCRELEX® is a registered trademark of Eton Pharmaceuticals, Inc. Eton and Eton Cares are trademarks of Eton Pharmaceuticals, Inc.

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

What is Severe Primary
IGF-1 Deficiency?
About INCRELEX^®
Staying on Treatment
Support & Resources

About Eton Pharmaceuticals
Privacy policy
Cookies notice
Contact us

© 2025 Eton Pharmaceuticals, Inc. All rights reserved. 1887-v5.

NOTE: You are about to leave an Eton Pharmaceuticals website. This link is provided as a service to our website visitors. It will take you to another site maintained by Eton Pharmaceuticals.